The potential rescheduling of cannabinoids, particularly at the federal level, is generating considerable anticipation within the market. A shift away from Schedule I status, often regarded as outdated and hindering https://sabrinaewcf958149.nytechwiki.com/16072/cannabinoid_rescheduling_a_growth_catalyst